Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:2606:159-170.
doi: 10.1007/978-1-0716-2879-9_12.

The Delivery of ABE mRNA to the Adult Murine Liver by Lipid Nanoparticles (LNPs)

Affiliations

The Delivery of ABE mRNA to the Adult Murine Liver by Lipid Nanoparticles (LNPs)

Dong Yang et al. Methods Mol Biol. 2023.

Abstract

A genetic disorder is a disease caused by an abnormal DNA sequence, and almost half of the known pathogenic monogenetic mutations are caused by G-to-A mutation (Landrum et al., Nucleic Acids Res 44:D862-868, 2016). Adenine base editors (ABE), developed from the CRISPR, hold the great promise to mediate the A-to-G transition in genomic DNA while not inducing DNA cleavage (Gaudelli et al., Nature 551:464-471, 2017). Additionally, lipid nanoparticles (LNPs), as a non-viral delivery, are able to deliver the ABE mRNAs and gRNA to the target tissues (Newby and Liu, Mol Ther 29:3107-3124, 2021). This chapter mainly introduces the production and LNP delivery of ABE mRNA and gRNA.

Keywords: ABE mRNA; Delivery; LNPs; Murine liver.

PubMed Disclaimer

References

    1. Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, Jang W, Katz K, Ovetsky M, Riley G, Sethi A, Tully R, Villamarin-Salomon R, Rubinstein W, Maglott DR (2016) ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44(D1):D862–D868. https://doi.org/10.1093/nar/gkv1222 - DOI
    1. Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A*T to G*C in genomic DNA without DNA cleavage. Nature 551(7681):464–471. https://doi.org/10.1038/nature24644 - DOI
    1. Li G, Li X, Zhuang S, Wang L, Zhu Y, Chen Y, Sun W, Wu Z, Zhou Z, Chen J, Huang X, Wang J, Li D, Li W, Wang H, Wei W (2022) Gene editing and its applications in biomedicine. Sci China Life Sci 65:660. https://doi.org/10.1007/s11427-021-2057-0 - DOI
    1. Chen YX, Zhi SY, Liu WL, Wen JK, Hu SH, Cao TQ, Sun HW, Li Y, Huang L, Liu YZ, Liang PP, Huang JJ (2020) Development of highly efficient dual-AAV split adenosine base editor for in vivo gene therapy. Small Methods 4(9):ARTN 2000309. https://doi.org/10.1002/smtd.202000309 - DOI
    1. Wang D, Tai PWL, Gao G (2019) Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 18(5):358–378. https://doi.org/10.1038/s41573-019-0012-9 - DOI

Publication types

LinkOut - more resources